Frontiers in cell and developmental biology

Stem cell therapy as a potential new treatment for Alzheimer's disease

Updated

Abstract

may offer a promising approach for due to its ability to replace damaged cells and improve the brain microenvironment.

  • Stem cells can differentiate into functional neurons or glial cells, potentially replacing damaged cells in Alzheimer's disease.
  • They secrete factors that may enhance the brain's environment and support neural health.
  • Stem cells could help regulate and promote the clearance of β-amyloid deposits, which are associated with disease progression.
  • Challenges such as low cell survival rates and immune rejection remain significant hurdles for effective treatment.
  • Future advancements in technology may enhance the clinical application of stem cell therapies for Alzheimer's disease.

Simplified

Key figures

FIGURE 1
Healthy vs : brain cells and pathological features involved in disease progression
Highlights key cellular changes and pathological markers that differentiate Alzheimer's disease from healthy brain tissue
fcell-13-1650885-g001
  • Panel Healthy
    Healthy brain section with normal , intact , and typical neurons
  • Panel Alzheimer's disease
    Alzheimer's brain section showing microglia with Aβ plaques, blood-brain barrier disruption with , and neurons containing aggregates
FIGURE 2
Media conditions and cell composition for human -derived neuron, astrocyte, and triculture
Sets up optimal media and timing for maintaining balanced neuron, astrocyte, and microglia cultures in a human cell model
fcell-13-1650885-g002
  • Panel A
    Schematic timeline of differentiation and media changes for neurons (iNs), astrocytes (iAs), and microglia (iMGs) before switching to (TCM)
  • Panel B
    Table listing compositions of neuron, astrocyte, microglia media, and five variations of triple culture media (TCM1–TCM5)
  • Panels C–E
    images of neurons (TUJ1/), astrocytes (/S100B), and microglia (/INPP5D) maintained in their specific media or TCM1–TCM5; neurons appear visibly denser in TCM1 and TCM2 compared to neuron media
  • Panel F
    Timeline of triculture workflow showing thawing, plating, and co-culture days for iNs, iAs, and iMGs
  • Panel G
    Bar plot of relative percentages of NeuN+ neurons (58%), IBA1+ microglia (25%), and CD44+ astrocytes (17%) at day 27 with representative immunostaining image
  • Panel H
    Representative images of 3-day and 6-day tricultures labeled for neurons (TUJ1), microglia (IBA1), and astrocytes (CD44)
  • Panel I
    showing protein expression of INPP5D, IBA1, TAU5, CD44, and GAPDH in tricultures and single cell-type cultures at days 3 and 6
FIGURE 3
Engrafted ES cell-derived neurons forming diverse neuronal types in developing rat brain
Highlights diverse neuronal morphologies and migration patterns of transplanted cells in developing brain regions
fcell-13-1650885-g003
  • Panel A
    Intraventricular clusters of donor cells and single-cell migration into various brain regions 20 days after transplantation
  • Panels B–D
    Higher magnification of donor cell incorporation into neocortex (B, C) and hypothalamus (D), with cortical neurons extending long axons into corpus callosum
  • Panels E–K
    Confocal images showing transplanted cells with varied morphologies: simple bipolar cells (E), complex pyramidal-like neurons in hippocampus CA1 (F), and multipolar cells in neocortex, septum, thalamus, and tectum (G–K)
  • Panel L
    Immunofluorescence with antibody revealing engrafted cells with immature, elongated migratory precursor phenotypes; arrow indicates mouse-specific DNA hybridization signal
FIGURE 4
levels in exposed to or H2O2 with or without
Highlights reduced oxidative stress intensity in neurons cocultured with MSCs compared to neurons alone exposed to AβOs or H2O2
fcell-13-1650885-g004
  • Panels A–D
    Hippocampal neurons exposed to vehicle show low (oxidative stress) with or without MSCs
  • Panels E–H
    Neurons exposed to AβOs show visibly higher DCF fluorescence than vehicle, which appears reduced when cocultured with MSCs
  • Panels I–L
    Neurons exposed to H2O2 show high DCF fluorescence that appears lower when cocultured with MSCs
  • Panels M–O
    Quantification shows increased DCF fluorescence in AβO- and H2O2-exposed neurons, which is significantly reduced by MSC coculture; MSCs alone show low fluorescence
1 / 4

Full Text

What this is

  • This review examines the potential of for (), a condition characterized by progressive neurodegeneration and cognitive decline.
  • Current treatments focus on symptomatic relief but do not halt disease progression, highlighting the need for innovative approaches.
  • offers mechanisms such as cell replacement, neuroprotection, and modulation of , which may address underlying pathological processes.
  • Challenges remain in clinical translation, including safety, efficacy, and standardization of treatment protocols.

Essence

  • shows promise for treating by addressing its underlying mechanisms, including cell replacement and modulation. However, significant challenges must be overcome for successful clinical application.

Key takeaways

  • Stem cells can differentiate into neurons and glial cells, potentially replacing damaged cells and repairing neural networks. This ability is crucial for addressing the cognitive decline seen in .
  • Stem cells secrete neurotrophic and anti-inflammatory factors that improve the brain's microenvironment. This paracrine signaling can enhance neuroregeneration and reduce , which are vital for slowing disease progression.
  • Despite encouraging results in animal models, clinical trials face challenges such as small sample sizes and variability in treatment protocols. Large, multicenter studies are essential to validate the efficacy and safety of stem cell therapies.

Caveats

  • Current clinical trials are mostly in early phases, limiting the understanding of long-term effects and safety of stem cell treatments for .
  • Variability in patient responses due to factors like age and disease stage complicates the effectiveness of stem cell therapies, necessitating personalized treatment approaches.
  • Challenges such as low cell survival rates and potential tumorigenicity of stem cells must be addressed to ensure safe and effective therapies.

Definitions

  • Alzheimer's disease (AD): A progressive neurodegenerative disorder characterized by memory impairment, cognitive decline, and behavioral dysfunction.
  • Stem cell therapy: A treatment approach using stem cells to repair or replace damaged cells and tissues, potentially addressing underlying disease mechanisms.
  • Neuroinflammation: The inflammatory response within the brain that can contribute to neuronal damage and is a key feature in the progression of Alzheimer's disease.

Simplified

Funding

Competing interests

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free